These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20572087)

  • 41. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study.
    Sagnelli E; Imparato M; Coppola N; Pisapia R; Sagnelli C; Messina V; Piai G; Stanzione M; Bruno M; Moggio G; Caprio N; Pasquale G; Del Vecchio Blanco C
    J Med Virol; 2008 Sep; 80(9):1547-53. PubMed ID: 18649338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy.
    El-Zayadi AR; Badran HM; Saied A; Shawky S; Attia Mel-D; Zalata K
    Am J Gastroenterol; 2009 Apr; 104(4):906-11. PubMed ID: 19293791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Markers of disease activity in chronic hepatitis B virus infection.
    Yalcin K; Degertekin H; Yildiz F; Celik Y
    Clin Invest Med; 2003 Feb; 26(1):27-34. PubMed ID: 12659467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.
    Ranki M; Schätzl HM; Zachoval R; Uusi-Oukari M; Lehtovaara P
    Hepatology; 1995 Jun; 21(6):1492-9. PubMed ID: 7768492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage.
    Lindh M; Horal P; Dhillon AP; Furuta Y; Norkrans G
    Hepatology; 1996 Sep; 24(3):494-501. PubMed ID: 8781313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads].
    Shi JP; Fan JG; Lou GQ; Zhang L; Hu CB; Wu R; Xun YH
    Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):818-22. PubMed ID: 19032864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the histological and serological parameters of patients with hepatitis delta virus in active and inactive hepatitis B virus carriers.
    Shaikh S; Ram DB; Tanveer S; Talpur A
    J Coll Physicians Surg Pak; 2014 Feb; 24(2):97-100. PubMed ID: 24491002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
    Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
    Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histopathology and clinical correlates of end-stage hepatitis B cirrhosis: a possible mechanism to explain the response to antiviral therapy.
    Sigal SH; Ala A; Ivanov K; Hossain S; Bodian C; Schiano TD; Min AD; Bodenheimer HC; Thung SN
    Liver Transpl; 2005 Jan; 11(1):82-8. PubMed ID: 15690540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients].
    Rüzgar M; Cetin Akhan S; Vahaboğlu H
    Mikrobiyol Bul; 2008 Apr; 42(2):283-91. PubMed ID: 18697426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis B virus load in serum does not reflect histologic activity in patients with decompensated cirrhosis.
    Kim JD; Choi JY; Bae SH; Yoon SK; Yang JM; Han NI; Choi SW; Lee CD; Lee YS; Jung ES
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):60-5. PubMed ID: 19804841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection.
    Waidmann O; Bihrer V; Pleli T; Farnik H; Berger A; Zeuzem S; Kronenberger B; Piiper A
    J Viral Hepat; 2012 Feb; 19(2):e58-65. PubMed ID: 22239527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Zukeran H
    J Med Virol; 2001 Nov; 65(3):478-84. PubMed ID: 11596082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and treatment of chronic hepatitis B: an update.
    Morgan M; Park W; Keeffe EB
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):25-41. PubMed ID: 17415343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B.
    Chan HL; Wong GL; Tse CH; Chim AM; Yiu KK; Chan HY; Sung JJ; Wong VW
    Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1361-6. PubMed ID: 19683072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Profile of asymptomatic chronic HBV infection in India.
    Chandra R; Kapoor D; Agarwal SR; Malhotra V; Sakhuja P; Sarin SK
    Indian J Med Res; 2002 Aug; 116():50-7. PubMed ID: 12592990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural history of hepatitis B in perinatally infected carriers.
    Boxall EH; Sira J; Standish RA; Davies P; Sleight E; Dhillon AP; Scheuer PJ; Kelly DA
    Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F456-60. PubMed ID: 15321970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
    J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.